Patents Assigned to Ablacon Inc.
-
Patent number: 11839445Abstract: Disclosed are various examples and embodiments of systems, devices, components and methods configured to detect a location of a source of at least one cardiac rhythm disorder in a patient's heart. In some embodiments, electrogram signals am acquired from inside a patient's heart, and subsequently normalized, adjusted and/or filtered, followed by generating a two-dimensional (2D) spatial map, grid or representation of the electrode positions, processing the amplitude-adjusted and filtered electrogram signals to generate a plurality of three-dimensional electrogram surfaces corresponding at least partially to the 2 D grid, one surface being generated for each or selected discrete times, and processing the plurality of three-dimensional electrogram surfaces through time to generate a velocity vector map corresponding at least partially to the 2 D grid.Type: GrantFiled: March 25, 2021Date of Patent: December 12, 2023Assignee: ABLACON, INC.Inventor: Peter Ruppersberg
-
Patent number: 11672465Abstract: Electrographic flow mapping (EGF mapping) is a technique used for aiding catheter ablation when treating atrial fibrillation. Visualizing EGF fields during a cardiac catherization and ablation procedure is an important and necessary part of conducting the procedure. Several different visualization methods are described and disclosed herein that may be employed to visualize EGF fields and maps, including quiver plots, streamline plots, particle plots, particle trail plots, moving particle plots, and moving and fading particle plots.Type: GrantFiled: July 1, 2020Date of Patent: June 13, 2023Assignee: Ablacon Inc.Inventors: David Emanuel LukÅic, Philip Haeusser, Peter Ruppersberg
-
Patent number: 11523762Abstract: Disclosed are various examples and embodiments of a cardiac mapping catheter configured for electrophysiological (EP) mapping and suitable for intravascular insertion in a patient's heart, and methods of making same. The cardiac mapping catheter comprises a plurality support arms having electrodes disposed thereon. Various configurations of the cardiac mapping catheter are described and disclosed which provide improved spatial resolution and sensing of EP signals acquired from inside a patient's heart.Type: GrantFiled: November 21, 2019Date of Patent: December 13, 2022Assignee: Ablacon Inc.Inventors: Peter Ruppersberg, Peter Jacobs
-
Patent number: 11484239Abstract: Disclosed are various examples and embodiments of systems, devices, components and methods configured to detect a location of a source of at least one cardiac rhythm disorder in a patient's heart.Type: GrantFiled: July 17, 2020Date of Patent: November 1, 2022Assignee: Ablacon Inc.Inventors: Philip Haeusser, Peter Ruppersberg
-
Patent number: 11471114Abstract: The present invention concerns a Medical system tor mapping of action potential data comprising an elongated medical mapping device (1) suitable for intravascular insertion having an electrode assembly (80) located at a distal portion (3) of the mapping device (1), a data processing and control unit (15) for processing data received from the mapping device (1), the data processing and control unit including a model generator for visualizing a 3-dimensional heart model based on one of electrical navigation system, MRI or CT scan data of a heart, a data output unit (16) for displaying both the 3-dimensional heart model and the processed data of the mapping device (1) simultaneously in a single visualization, wherein the model generator is configured to structure 3D scan data of the heart into 6 directions (a, b, c, d, e or f) of a cube, each direction is associated with a separate Cartesian coordinate system with X(a, b, c, d, e or f), Y(a, b, c, d, e or f), Z(a, b, c, d, e or f) coordinates, wherein for assignType: GrantFiled: January 19, 2016Date of Patent: October 18, 2022Assignee: Ablacon Inc.Inventor: Peter Ruppersberg
-
Patent number: 11389102Abstract: Disclosed are various examples and embodiments of systems, devices, components and methods configured to detect a location of a source of at least one cardiac rhythm disorder in a patient's heart. In some embodiments, electrogram signals are acquired from a patient's body surface, and subsequently normalized, adjusted and/or filtered, followed by generating a two-dimensional spatial map, grid or representation of the electrode positions, processing the amplitude-adjusted and filtered electrogram signals to generate a plurality of three-dimensional electrogram surfaces corresponding at least partially to the 2D map, one surface being generated for each or selected discrete times, and processing the plurality of three-dimensional electrogram surfaces through time to generate a velocity vector map corresponding at least partially to the 2D map.Type: GrantFiled: December 21, 2019Date of Patent: July 19, 2022Assignee: Ablacon Inc.Inventors: Philip Haeusser, Peter Ruppersberg
-
Patent number: 10980418Abstract: Disclosed are various examples of embodiments of systems, devices, components and methods configured to detect a location of a source of at least one cardiac rhythm disorder in a patient's heart. In some embodiments, electrogram signals are acquired from inside a patient's heart, and subsequently normalized, adjusted and/or filtered, followed by generating a two-dimensional (2D) spatial map, grid or representation of the electrode positions, processing the amplitude-adjusted and filtered electrogram signals to generate a plurality of three-dimensional electrogram surfaces corresponding at least partially to the 2 D grid, one surface being generated for each or selected discrete times, and processing the plurality of three-dimensional electrogram surfaces through time to generate a velocity vector map corresponding at least partially to the 2 D grid.Type: GrantFiled: December 24, 2018Date of Patent: April 20, 2021Assignee: Ablacon Inc.Inventor: Peter Ruppersberg
-
Patent number: 10888391Abstract: The present invention concerns an elongated medical device (1) suitable for intravascular insertion. Said device comprising a flexible elongated body (2) having a distal portion (3) with a distal end (4) and a proximal portion (5) and an optic force sensing assembly (20) disposed within said flexible elongated body (2) proximate said distal end.Type: GrantFiled: May 29, 2015Date of Patent: January 12, 2021Assignee: Ablacon IncInventor: Peter Ruppersberg
-
Patent number: 10888236Abstract: The present invention concerns a system (100) for analyzing electrophysiological data, especially intracardial electrogram data, the system (100) comprising a data processing and control unit (15) for processing the electrophysiological data, a data output unit comprising a data output screen (324) for displaying results of electrophysiological data analysis, wherein the data processing and control unit (15) being configured to receive electrophysiological data obtained from a mapping catheter assembly (110, 111) that comprises an electrode assembly (120, 80) with a plurality of n electrodes (82), each electrode (82) configured for measuring electrophysiological data in the form of electrogram signals.Type: GrantFiled: September 7, 2016Date of Patent: January 12, 2021Assignee: Ablacon Inc.Inventor: Peter Ruppersberg
-
Patent number: 10813590Abstract: Disclosed are various examples and embodiments of a cardiac mapping catheter configured for electrophysiological (EP) mapping and suitable for intravascular insertion in a patient's heart, and methods of making same. The cardiac mapping catheter comprises a plurality support arms having electrodes disposed thereon. Various configurations of the cardiac mapping catheter are described and disclosed which provide improved spatial resolution and sensing of EP signals acquired from inside a patient's heart.Type: GrantFiled: October 25, 2017Date of Patent: October 27, 2020Assignee: Ablacon Inc.Inventor: Peter Ruppersberg
-
Patent number: 10143374Abstract: Disclosed are various examples and embodiments of systems, devices, components and methods configured to detect a location of a source of at least one cardiac rhythm disorder in a patient's heart. In some embodiments, electrogram signals are acquired from inside a patient's heart, and subsequently normalized, adjusted and/or filtered, followed by generating a two-dimensional spatial map, grid or representation of the electrode positions, processing the amplitude-adjusted and filtered electrogram signals to generate a plurality of three-dimensional electrogram surfaces corresponding at least partially to the 2D map, one surface being generated for each or selected discrete times, and processing the plurality of three-dimensional electrogram surfaces through time to generate a velocity vector map corresponding at least partially to the 2D map.Type: GrantFiled: September 7, 2016Date of Patent: December 4, 2018Assignee: Ablacon Inc.Inventor: Peter Ruppersberg